Company news
Jiangsu Gdk Biotechnology Co., Ltd. Class A (SSE:688670) news
Jiangsu Gdk Biotechnology Co., Ltd. Class A news releases on 6ix. Latest, Sep 10, 2026: "JIANGSU GDK BIOLOGICAL TECHNOLOGY CO., LTD."Announcement on Convening…
Press releases & updates
"JIANGSU GDK BIOLOGICAL TECHNOLOGY CO., LTD."Announcement on Convening the 2026 Semi-annual Performance Briefing
September 9, 2026
"JIANGSU GDK BIOLOGICAL TECHNOLOGY CO., LTD."Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026
August 20, 2026
"JIANGSU GDK BIOLOGICAL TECHNOLOGY CO., LTD."Announcement on Renewal of Joint Control and Concerted Action Agreement by Controlling Shareholder and Joint Actual Controllers
August 3, 2026
Announcement on Reply to Regulatory Inquiry Letter Regarding Information Disclosure of 2025 Annual Report
June 7, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 14, 2026
Notice on Convening the 2025 Annual General Meeting
April 22, 2026
Announcement on Resignation of Senior Management Member
March 20, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 12, 2026
Earnings Preannouncement for 2025
January 30, 2026
Announcement on Resignation of Securities Affairs Representative
December 1, 2025
Announcement on Abnormal Fluctuations in Stock Trading
November 26, 2025
Announcement on Appointment of General Manager and Adjustment to the Members in the Audit Committee of Board of Directors
November 11, 2025
Announcement on Convening the Q3 2025 Performance Briefing
October 24, 2025
Announcement on Passing of the General Manager
September 10, 2025
Full Text of 2025 Semi-annual Report
August 21, 2025
Announcement on Resignation of Supervisor and By-election of Employee Representative Supervisor
June 16, 2025
Announcement on Reply to Regulatory Inquiry Letter Regarding Information Disclosure of 2024 Annual Report
June 5, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 9, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 27, 2025
Announcement on the Special Action Plan for "Corporate Value and Return Enhancement" Special Action Plan for 2025
January 17, 2025
Announcement on Voluntary Disclosure of the Company Re-Certified as a High-Tech Enterprise
December 3, 2024
Report for Q3 2024
October 24, 2024
Announcement on Reply to Letter of Supervision and Inquiry on Information Disclosure of 2024 Semi-annual Report
September 3, 2024
Full Text of Semi-annual Report in 2024
August 20, 2024
Announcement on Renewal of the Agreement on Joint Control and Concerted Action by Controlling Shareholders and Joint Actual Controllers
July 25, 2024
Announcement on Adjustment of Products' Prices
June 12, 2024
Announcement on Resignation and Appointment of Senior Management Member
May 31, 2024
Announcement on Resolutions of 2023 Annual General Meeting
May 8, 2024
Announcement on Convening 2023 Annual Performance Meeting
April 15, 2024
Announcement on 2023 Annual Preliminary Earnings Estimate
February 23, 2024
2023 Annual Performance Forecast
January 30, 2024
Announcement on Completing Cancellation of Wholly-owned Subsidiary
January 11, 2024
Announcement on Release of Freeze over Some Funds in Special Accounts for Raised Funds
January 10, 2024
Announcement on Freezing over Some Funds in Special Account for Raised Funds
January 9, 2024
Announcement on Resignation and Appointment of Senior Management Members
December 25, 2023
Announcement on Voluntary Disclosure of Obtaining Lot Release by Company's Quadrivalent Influenza Vaccine for 2023-2024 Influenza Season
December 19, 2023
Announcement on Resignation of Independent Director
December 7, 2023
Announcement on Follow-up Progress in Temporary Suspension of Production
November 3, 2023
3rd Quarter Report of 2023
October 27, 2023